LABU240823P109000
- 0.91
- 0.000.00%
Direxion Daily S&P Biotech Bull 3x Shares ETF Newsroom
Rivian, Chipotle Mexican And Sirius XM Are Among Top 10 Large Cap Losers Last Week (Aug 11-Aug 17): Are The Others In Your Portfolio?
J&J, Roche Come Out on Top in S&P Ratings of Strongest Pharma Companies
Trending Stocks This Week as U.S. Equities Notch Their Best Week of 2024
Catalyst Watch: Eyes on Jackson Hole, Target Earnings, and Canadian Rails Disruption
Alnylam Pharmaceuticals Analyst Ratings
Liquidia Draws Bullish View at Raymond James on Yutrepia Potential
The only manufacturer of smallpox vaccine has submitted clinical data and plans to expand the scope of vaccination.
Bavarian Nordic announced that it has submitted clinical data to the European Medicines Agency to seek an expansion of the indication for its Imvanex vaccine to adolescents aged 12-17. Yesterday, Sweden, the neighboring country of Denmark, reported the first confirmed case of monkeypox, which is also the first case confirmed outside the African continent since this epidemic outbreak.
Glenview Capital's Q2 Moves Include Selling Broadcom After Just One Quarter, Exiting Meta
Alvotech's Biosimilar to Regeneron's Eylea Under EU Review
FDA Approves Gilead's Seladelpar For Inflammatory Liver Disease, Acquired Via $4B CymaBay Deal
Expert Outlook: Gilead Sciences Through The Eyes Of 8 Analysts
U.S. Announces Final Drug Prices After Medicare Negotiations
Gilead Sciences Analyst Ratings
U.S. Government Targets $6B in Saving From First Medicare Drug Price Negotiations
Gilead Wins FDA Nod for Liver Disease Drug
Decoding AbbVie's Options Activity: What's the Big Picture?
The 28 Companies in BMO Capital's High-quality Stock Screen
9 Health Care Stocks Whale Activity In Today's Session
Insights Into Regeneron Pharmaceuticals's Performance Versus Peers In Biotechnology Sector
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome